Carl Zeiss Meditec (ETR:AFX) Trading Down 1% – Here’s What Happened

Carl Zeiss Meditec AG (ETR:AFX) shares traded down 1% during trading on Wednesday . The stock traded as low as €27.46 and last traded at €27.56. 296,471 shares traded hands during trading, an increase of 214% from the average session volume of 94,405 shares. The stock had previously closed at €27.84.

Carl Zeiss Meditec Price Performance

The company has a debt-to-equity ratio of 7.41, a quick ratio of 2.47 and a current ratio of 2.13. The company has a market cap of $2.57 billion, a price-to-earnings ratio of 14.73, a PEG ratio of 2.83 and a beta of 0.98. The business has a fifty day moving average price of €38.69 and a 200 day moving average price of €42.54.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.